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In an investigation of 201 prostate tissue samples from patients with benign prostate hyperplasia that later progressed to prostate
cancer and 201 matched controls that did not, there were no differences in the prevalence of adenovirus, herpesvirus, papilloma
virus, polyoma virus and Candida albicans DNA.
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Mutations in genes associated with the immune defence have been
identified in hereditary prostate cancer, indicating that infection
and/or inflammation of the prostate may be important mediators
for the development of prostate cancer (Palapattu et al, 2005; Sun
et al, 2005). Moreover, population studies have revealed an
increased relative risk for development of prostate cancer in men
with a prior history of sexually transmitted infections (Dennis and
Dawson, 2002). These findings support the hypothesis that an
infectious agent can be a potential cofactor in prostate cancer
development. Human papilloma virus (HPV), Epstein–Barr virus
(EBV) and the polyoma viruses JCV and BKV represent viruses
with proven linkage to different human cancers and have been
traced in prostate cancer tissues (Grinstein et al, 2002; Zambrano
et al, 2002). To further evaluate if a viral infection could contribute
to prostate cancer development, we conducted a case–control
study of 402 patients with benign prostate hyperplasia (BPH), of
which 201 later progressed to prostate cancer. We examined
whether the presence of genetic traces of EBV, herpes simplex
virus (HSV) 1 and 2, cytomegalovirus (CMV), adenovirus, HPV,
polyoma viruses BKV and JCV and Candida albicans in the
prostate correlate with histological inflammation and subsequent
prostate cancer diagnosis.
MATERIALS AND METHODS
A case–control study of 402 archival prostate tissue samples
obtained during transurethral resection of the prostate (TURP)
collected at the Department of Pathology at the University Hospital
of Northern Sweden, Umea ˚ was conducted as described previously
(Alexeyev et al, 2006; Bergh et al, 2006). Briefly, tissues were
obtained from men with BPH (median age 64, range 51–71), fixed
in formalin, paraffin-embedded and stored at room temperature
until tested. A total of 201 men developed prostate cancer at least 6
months after the TURP. For each case, a control was randomly
selected from a cohort of patients that did not develop prostate
cancer. The case–control pairs were matched for year of birth,
residence and year of TURP. Histological inflammation was graded
as mild or severe as described (Alexeyev et al, 2006). DNA from
prostate tissue was purified and checked for integrity as described
(Alexeyev et al, 2006). Nested PCR assays were used for all the
assays except HPV and C. albicans PCRs. Primers and PCR
protocols for adenovirus (Allard et al, 2001), CMV (Brytting et al,
1991), EBV (Meyohas et al, 1996), HSV1 and 2 (Aurelius et al,
1991) and HPV (de Roda Husman et al, 1995) were used with
minor modifications. Primers for the polyoma viruses JCV and
BKV and C. albicans were designed according to published
sequence information (Table 1). To verify the positive PCR
findings, PCR products were purified with QIAquick Purification
Kit protocol (Qiagen
s, Hilden, Germany) and directly sequenced
in the ABI PRISM 3700 DNA ANALYSER (AME Bioscience,
Toroed, Norway) using the Big Dyet Terminator Cycle Sequencing
kit 1.1 (Applied Biosystems, Forster City, CA, USA). Histological
inflammation in prostate tissue was graded as described earlier
(Alexeyev et al, 2006). Fisher exact test was used for statistical
analysis.
RESULTS
Out of 402 samples tested, 352 (87.6%) were positive for the human
b-globin gene. These samples were considered to have sufficient
DNA quality and were therefore used for subsequent analysis in
viral and fungal PCRs. Of the 352 samples tested, 31 (8.8%) were
positive for EBV and 10 (2.8%) for JCV. No other viral DNAs were
detected. Of 240 samples that were available for C. albicans-specific
PCR, two were (0.8%) positive. We then assessed whether the
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ydetection of EBV, JCV and C. albicans in the prostate correlates
with subsequent prostate cancer diagnosis. In total, 159 matched
case–control pairs with complete information on EBV and JCV
and 115 pairs with complete information for C. albicans
were available. Of the 29 positive EBV samples, 15 (9.4%) were
in the case group (progressed to cancer) and 14 (8.8%) were in the
control group. Of 10 positive JCV samples, three (1.9%) were in
the case group and seven (4.4%) were in the control group.
The two samples scored positive for C. albicans were found in
the case group. There was no difference in the occurrence of severe
inflammation in EBV- or JCV-positive samples vs virus-negative
samples (data not shown).
DISCUSSION
To the best of our knowledge, this is the first study investigating
the presence of eight different DNA viruses and C. albicans in a
large series of men with BPH. Owing to the case–control design of
the present study, it had a potential to evaluate if viral/fungal
infection could precede and, possibly, contribute to prostate
inflammation and prostate cancer development. Only archival
samples positive for the b-globin gene were subsequently tested for
microbial DNAs, thus ensuring good quality DNA and absence of
PCR inhibitors. Of eight DNA viruses tested, only EBV and JCV
were found in the prostate tissue. This observation is in accord
with previous studies (Grinstein et al, 2002; Zambrano et al, 2002).
These viruses are unlikely to contribute to prostate cancer
development in the patients studied owing to the similar
occurrence in the case and control groups. Data on the presence
of HPV in benign and malignant prostate tissues are contradictory.
Some groups have reported high rates of detection (Noda et al,
1998; Serth et al, 1999; Zambrano et al, 2002), whereas others have
not found HPV (Effert et al, 1992; Strickler et al, 1998). All samples
tested in this study were negative for HPV, thus making it an
unlikely contributing factor for subsequent cancer development in
the 352 patients studied. Our study did not find any association
between the presence of EBV and JCV and histological inflamma-
tion in the prostate. These viruses are therefore unlikely as
triggering factors of chronic prostate inflammation. In conclusion,
our study has shown that the prostate can harbour mixed
microbial communities. Epstein–Barr virus, JCV and C. albicans
do not appear to contribute to chronic prostate inflammation and
subsequent prostate cancer development.
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